FDA ends premarket review exception for COVID-19 laboratory developed tests

Nov 16, 2021 - 08:43 AM
FDA-guidance

To ensure that COVID-19 tests work as intended, the Food and Drug Administration will now enforce premarket review requirements for laboratory developed tests, reversing the prior administration’s policy, Health and Human Services Secretary Xavier Becerra announced yesterday. 

FDA said it generally intends to focus its review on emergency use authorization requests for at-home and point-of-care diagnostic tests that can be manufactured in high volumes; certain high-volume, lab-based molecular diagnostic tests and point-of-care antibody tests; and tests supported by federal stakeholders such as the Biomedical Advanced Research and Development Authority or National Institutes of Health. For details, see the FDA’s updated guidance for COVID-19 test developers during the public health emergency. 

Laboratory developed tests are developed, validated and performed by individual laboratories, including hospital laboratories, when commercial diagnostic tests do not exist or meet clinical needs. 
 

Related News Articles

Headline
CDC recommends two doses of COVID-19 vaccine for older individuals, lowers pneumococcal vaccine age 
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
CMS releases final guidance on hospital respiratory data condition of participation reporting requirements 
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
FDA authorizes combination tests for flu, COVID-19
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
CDC: COVID-19 surging across the U.S.
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
CDC issues advisory on increased parvovirus B19 cases in the U.S. 
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
CDC encourages older adults to get additional COVID-19 vaccine dose 
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…